Literature DB >> 19413821

Acquired hypernatraemia is an independent predictor of mortality in critically ill patients.

S D O'Donoghue1, J M Dulhunty, H K Bandeshe, S Senthuran, J R Gowardman.   

Abstract

This study reports the incidence and associated mortality of acquired hypernatraemia (Na > 150 mmol x l(-1)) in a general medical/surgical intensive care unit. Patients admitted over a 5-year period with normal sodium values were eligible for inclusion; exclusions were made for burn/neurosurgical diagnoses and for hypertonic saline therapy. From 3475 admissions (3317 patients), 266 (7.7%) episodes of hypernatraemia were observed. Hospital mortality was 33.5% in the hypernatraemic group and 7.7% in the normonatraemic group (p < 0.001). Acquired hypernatraemia was an independent risk factor for in-hospital mortality (OR 1.97, 95% CI 1.37-2.82, p < 0.001). Intermediate sodium levels (145-150 mmol x l(-1)) were associated with increased mortality (OR 1.42, 95% CI 1.02-1.98). Uncorrected sodium at discharge (p = 0.001) and peak sodium (p = 0.001) were better predictors of mortality than time to onset (p = 0.71) and duration of hypernatraemia (p = 1.0). Hypernatraemia avoidance is justified, but determinants of hypernatraemia and benefits of targeted treatment strategies require further elucidation.

Entities:  

Mesh:

Year:  2009        PMID: 19413821     DOI: 10.1111/j.1365-2044.2008.05857.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  14 in total

1.  Crystalloid fluid therapy: is the balance tipping towards balanced solutions?

Authors:  Paul J Young; Michael Joannidis
Journal:  Intensive Care Med       Date:  2014-11-11       Impact factor: 17.440

2.  Choice of crystalloids in sepsis: a conundrum waiting to be solved.

Authors:  Ying Wei Yau; Win Sen Kuan
Journal:  Ann Transl Med       Date:  2016-03

3.  Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation.

Authors:  Michael D Leise; Byung Cheol Yun; Joseph J Larson; Joanne T Benson; Ju Dong Yang; Terry M Therneau; Charles B Rosen; Julie K Heimbach; Scott W Biggins; W Ray Kim
Journal:  Liver Transpl       Date:  2014-06       Impact factor: 5.799

4.  Severity of community acquired hypernatremia is an independent predictor of mortality.

Authors:  Woo Jin Jung; Hee Jeong Lee; Suyeon Park; Si Nae Lee; Hye Ran Kang; Jin Seok Jeon; Hyunjin Noh; Dong Cheol Han; Soon Hyo Kwon
Journal:  Intern Emerg Med       Date:  2017-05-04       Impact factor: 3.397

5.  Increased mortality in hypernatremic burned patients.

Authors:  Thomas Namdar; Frank Siemers; Peter L Stollwerck; Felix H Stang; Peter Mailänder; Thomas Lange
Journal:  Ger Med Sci       Date:  2010-06-07

6.  Does hypernatremia impact mortality in Toxic Epidermal Necrolysis?

Authors:  Thomas Namdar; Tobias von Wild; Frank Siemers; Peter L Stollwerck; Felix H Stang; Peter Mailänder; Thomas Lange
Journal:  Ger Med Sci       Date:  2010-11-02

7.  Role of NFAT5 in inflammatory disorders associated with osmotic stress.

Authors:  Wolfgang Neuhofer
Journal:  Curr Genomics       Date:  2010-12       Impact factor: 2.236

8.  Long-term changes in dysnatremia incidence in the ICU: a shift from hyponatremia to hypernatremia.

Authors:  Annemieke Oude Lansink-Hartgring; Lara Hessels; Joachim Weigel; Anne Marie G A de Smet; Diederik Gommers; Prashant V Nannan Panday; Ewout J Hoorn; Maarten W Nijsten
Journal:  Ann Intensive Care       Date:  2016-03-17       Impact factor: 6.925

9.  The association between intensive care unit-acquired hypernatraemia and mortality in critically ill patients with cerebrovascular diseases: a single-centre cohort study in Japan.

Authors:  Takahiro Imaizumi; Masahiro Nakatochi; Yoshiro Fujita; Rie Nomura; Kenshi Watanabe; Michitaka Maekawa; Taishi Yamakawa; Takayuki Katsuno; Shoichi Maruyama
Journal:  BMJ Open       Date:  2017-08-18       Impact factor: 2.692

10.  Dysnatremia is an Independent Indicator of Mortality in Hospitalized Patients.

Authors:  Jiachang Hu; Yimei Wang; Xuemei Geng; Rongyi Chen; Pan Zhang; Jing Lin; Jie Teng; Xiaoyan Zhang; Xiaoqiang Ding
Journal:  Med Sci Monit       Date:  2017-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.